A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer

scientific article published in February 2010

A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/JTO.0B013E3181C5E334
P698PubMed publication ID20009775

P2093author name stringLisa A Rybicki
Jerrold P Saxton
Thomas W Rice
Gregory M M Videtic
David P Mason
Sudish C Murthy
David J Adelstein
Cristina P Rodriguez
Denise I Ives
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectchemotherapyQ974135
P1104number of pages7
P304page(s)229-235
P577publication date2010-02-01
P1433published inJournal of Thoracic OncologyQ2448056
P1476titleA phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer
P478volume5

Reverse relations

cites work (P2860)
Q84814758A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction
Q35218636A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage
Q47870382Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer: A Propensity Score-Matched Analysis.
Q38153443Advances in biomarkers for esophageal cancer
Q26825957Advances in targeted therapies and new promising targets in esophageal cancer
Q58484643Barrett's esophagus: treatments of adenocarcinomas II
Q38263841Clinical management of advanced gastric cancer: the role of new molecular drugs.
Q38720829Current advances in targeted therapies for metastatic gastric cancer: improving patient care
Q38006438Current developments in the management of locally advanced esophageal cancer
Q39025928EGFR family and cMet expression profiles and prognostic significance in esophagogastric adenocarcinoma.
Q38110962Emerging tyrosine kinase inhibitors for esophageal cancer
Q92761225Esophageal cancer research today and tomorrow: Lessons from algae and other perspectives
Q49887971Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma.
Q37038482Genomic alterations in advanced esophageal cancer may lead to subtype-specific therapies
Q37368954Identification of exon 19 and 21 mutations of EGFR gene in Chinese patients with esophageal squamous cell carcinoma
Q37207101Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan.
Q38221886Investigational therapies targeting the ErbB family in oesophagogastric cancer
Q41907024Metastatic gastric cancer - focus on targeted therapies
Q38869420Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology
Q38161727Molecular targeted agents for gastric cancer: a step forward towards personalized therapy.
Q36705689Molecular targeted therapy for advanced gastric cancer
Q26851986Outcome reporting in neoadjuvant surgical trials: a systematic review of the literature and proposals for new standards
Q39204464Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer
Q38199128Recent advances and future trends in the targeted therapy of metastatic gastric cancer
Q36475391Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action
Q38364292Targeted therapy in gastric cancer
Q37862077Targeting the human EGFR family in esophagogastric cancer
Q27853383The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma
Q38222585The role of targeted therapy for gastrointestinal tumors.
Q28073690Translational research in thoracic surgery-the National Taiwan University Hospital experience

Search more.